All Fusobacterium nucleatum articles
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.
-
NewsInnovations in cancer treatment through targeted bacterial vaccines
Scientists outline efforts to create an antibacterial vaccine capable of eliciting robust immune responses to selectively eradicate Fusobacterium nucleatum while preserving other microbiota.
-
NewsCommonly used alcohol-based mouthwash brand disrupts the balance of oral microbiome
Researchers have identified a significant change in composition and abundance of bacteria in study participants’ oral microbiomes after using a popular brand of alcohol-based mouthwash.
-
NewsRemoving gut bacteria’s potential ‘safe house’ may lower risk of colorectal cancer subtype
A new study has found an association between appendix removal and a decreased risk of colorectal cancer positive for tumor-promoting bacteria.
-
NewsScientists reveal interaction mechanism between intestinal microbial environment and tumor immune microenvironment
Scientists have unveiled the mechanism of tumor immune evasion mediated by the microorganism C. scindens in colorectal cancer. Additionally, they developed a phage-based intervention method.
-
NewsBacteria subtype linked to growth in up to 50% of human colorectal cancers
A new study suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments.
-
NewsRapid specific detection of oral pathogens using CRISPR-based diagnostics
A study aiming to develop a low-cost, rapid detection technique for the widescale detection and screening of oral microorganisms suitable for point-of-care settings was presented at the 102nd General Session of the IADR.
-
NewsBacterial metabolite activates another species to produce bad breath
Researchers find that a metabolite produced by the commensal oral bacterium Streptococcus gordonii activates another bacterial species, Fusobacterium nucleatum, to produce the malodorous compound methyl mercaptan.
-
NewsStudy confirms protective role of bacterium in chronic rhinosinusitis
Scientists investigate how microbes in the nasal mucosa may influence the pathophysiology of chronic sinusitis.
-
NewsResearchers find regulatory mechanism that keeps cancer-causing bacteria in check
Researchers have discovered an important mechanism that may have profound implications for how we prevent colorectal cancer.
